ATNM vs CRL · rev $35.0M vs rev $4.02B
Actinium Pharmaceuticals Inc (ATNM) versus Charles River Laboratories (CRL) — a side-by-side from cached financials, not a winner call.
Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Latest reported ATNM revenue for 2026-06-30 was $35.0M. Net income was $22.4M. Revenue was up 38788.9% from 2025-09-30 to 2026-06-30. ATNM currently screens at market cap $33.9M.
Latest reported CRL revenue for 2025-12-27 was $4.02B. Net income was -$144.3M. CRL currently screens at market cap $7.78B.
ATNM currently screens at market cap $33.9M. CRL currently screens at market cap $7.78B.
Not investment advice. Open the ATNM and CRL stock pages for the full models.
Not investment advice.